Overview

Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Status:
RECRUITING
Trial end date:
2027-05-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.
Phase:
PHASE1
Details
Lead Sponsor:
SystImmune Inc.